Abstract: The ever-growing scale of data parallelism in today's HPC and ML applications presents a big challenge for computing architectures' energy efficiency and performance. Vector processors ...
This important study presents a thoughtful design and characterization of chimeric influenza hemagglutinin (HA) head domains combining elements of distinct receptor-binding sites. The results provide ...
The Company treated the first patient in the pivotal Phase 3 OVATION 3 Study in July 2025 and is working with trial investigators to expand clinical sites and accelerate enrollment. Four sites have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback